BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7972255)

  • 1. Protein kinase C in signal transduction and carcinogenesis.
    Blumberg PM; Acs G; Areces LB; Kazanietz MG; Lewin NE; Szallasi Z
    Prog Clin Biol Res; 1994; 387():3-19. PubMed ID: 7972255
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells.
    Dell'Aquila ML; Herald CL; Kamano Y; Pettit GR; Blumberg PM
    Cancer Res; 1988 Jul; 48(13):3702-8. PubMed ID: 3132318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and by bryostatin 1.
    Pasti G; Rivedal E; Yuspa SH; Herald CL; Pettit GR; Blumberg PM
    Cancer Res; 1988 Jan; 48(2):447-51. PubMed ID: 3422054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of protein kinase C in growth control and the concept of carcinogenesis as a progressive disorder in signal transduction.
    Weinstein IB
    Adv Second Messenger Phosphoprotein Res; 1990; 24():307-16. PubMed ID: 2119643
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
    Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
    Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complexes of phorbol tumor promoters with protein kinase C].
    Kozhemiakina OV; Iaguzhinskiĭ LS
    Biokhimiia; 1990 Apr; 55(4):595-607. PubMed ID: 2198948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
    Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
    Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C control of gene expression.
    Ventura C; Maioli M
    Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):243-67. PubMed ID: 11693964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of novel protein kinase C delta in BL6 murine melanoma cells inhibits the proliferative capacity in vitro but enhances the metastatic potential in vivo.
    La Porta CA; Di Dio A; Porro D; Comolli R
    Melanoma Res; 2000 Apr; 10(2):93-102. PubMed ID: 10803709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protein kinase C. Key enzyme for immune reactions and cell growth].
    Hellwiq B
    Med Monatsschr Pharm; 1994 Nov; 17(11):326-8. PubMed ID: 7823874
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of phorbol esters on cell functions].
    Kawiak J
    Postepy Biochem; 1989; 35(3):265-77. PubMed ID: 2700788
    [No Abstract]   [Full Text] [Related]  

  • 12. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W; Rosenberg MP; DiGiovanni J
    Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture.
    Blumberg PM
    Cancer Res; 1988 Jan; 48(1):1-8. PubMed ID: 3275491
    [No Abstract]   [Full Text] [Related]  

  • 14. The heterogeneity of protein kinase C in signal transduction cascade.
    Ogita K; Koide H; Kikkawa U; Kishimoto A; Nishizuka Y
    Adv Second Messenger Phosphoprotein Res; 1990; 24():218-23. PubMed ID: 2169801
    [No Abstract]   [Full Text] [Related]  

  • 15. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
    Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C.
    Wender PA; Cribbs CM; Koehler KF; Sharkey NA; Herald CL; Kamano Y; Pettit GR; Blumberg PM
    Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7197-201. PubMed ID: 3174627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexities of the protein kinase C pathway.
    Blumberg PM
    Mol Carcinog; 1991; 4(5):339-44. PubMed ID: 1910477
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of intercellular communication in BALB/c 3T3 cell transformation.
    Yamasaki H; Enomoto T
    Carcinog Compr Surv; 1985; 9():179-94. PubMed ID: 4053073
    [No Abstract]   [Full Text] [Related]  

  • 19. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.
    Wang QJ; Fang TW; Yang D; Lewin NE; Van Lint J; Marquez VE; Blumberg PM
    Mol Pharmacol; 2003 Dec; 64(6):1342-8. PubMed ID: 14645664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol esters: structure, biological activity, and toxicity in animals.
    Goel G; Makkar HP; Francis G; Becker K
    Int J Toxicol; 2007; 26(4):279-88. PubMed ID: 17661218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.